Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

317
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
317
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

6.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
6.1K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

349
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
349
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.8K
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

101
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
101
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

734
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
734

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TET1 noncatalytic activity shapes the chromatin landscape associated with de novo methylation establishment in the male germline.

Genes & development·2026
Same author

Mouse offspring conceived by in vitro fertilization exhibit accelerated reproductive aging through early ovarian failure.

The Journal of clinical investigation·2026
Same author

A humidity-responsive ethylene sustained-release complex: Encapsulating ethephon with porous starch‑sodium alginate as matrix for uniform fruit ripening.

International journal of biological macromolecules·2026
Same author

Response to letter to the editor: Investigating the impact of RapidPlan on Ethos automated planning.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same author

Effects of stilbenoids on growth, mycotoxin production and transcriptomic profiles of Aspergillus carbonarius causing postharvest black spot disease.

World journal of microbiology & biotechnology·2026
Same author

In Vitro Fertilization Accelerates Female Reproductive Aging Through Early Ovarian Failure.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Apr 13, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K

Feasibility of using geometry-based synthetic dose distributions for Knowledge-based planning model training.

S A Yoganathan1, Congwu Cui1, Todd Stevens1

  • 1Radiation Oncology, Saint John Regional Hospital, Horizon Health Network, Saint John, NB, Canada.

Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)
|April 11, 2026
PubMed
Summary

Synthetic dose distributions generated from geometry effectively train knowledge-based planning models. This approach improves organ-at-risk sparing and reduces reliance on extensive clinical data for radiation therapy planning.

Keywords:
Knowledge-based planningPlanningRadiotherapyRapidplanSynthetic dose

More Related Videos

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

16.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K

Related Experiment Videos

Last Updated: Apr 13, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

16.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Computational Biology

Background:

  • Knowledge-based planning (KBP) tools require large clinical datasets for training.
  • Data collection is challenging, especially in resource-limited settings.
  • This study explores synthetic data as an alternative for KBP model training.

Purpose of the Study:

  • To evaluate geometry-based synthetic dose distributions as training data for RapidPlan (RP).
  • To compare the performance of models trained with synthetic data (synRP) against those trained with clinical data (clRP).

Main Methods:

  • Developed a tool to generate synthetic dose distributions from target and organ-at-risk (OAR) geometry.
  • Trained synRP models using synthetic doses for head-and-neck (HN) and prostate cancer cases.
  • Compared synRP models with clRP models using plan quality (target coverage, OAR doses, monitor units) and deliverability (portal dosimetry).

Main Results:

  • Target coverage was equivalent between synRP and clRP models.
  • synRP demonstrated improved OAR sparing in both prostate and HN cases.
  • Both synRP and clRP plans achieved high deliverability, passing portal dosimetry evaluations.

Conclusions:

  • Geometry-based synthetic dose distributions are effective training data for KBP.
  • This method allows for KBP model development with improved OAR sparing and reduced dependence on large clinical datasets.
  • Offers a practical and resource-efficient solution for KBP implementation, particularly in centers with limited data resources.